Mosquitoes that landed on surfaces coated with the antimalarial compound atovaquone were completely blocked from developing Plasmodium falciparum (P. falciparum), the parasite that causes malaria, according to new research.
Venezuela’s health crisis continues to abound and infectious diseases have been rising year after year to include measles, diphtheria, and malaria. The number of reported cases of malaria grew from 136,402 in 2015 to 240,613 in 2016 and 406,000 in 2017.
Scientists have developed a novel way with genome sequences to study and better understand transmission, treat and ultimately eradicate Plasmodium vivax, the most widespread form of malaria.
Unlike so-called ‘self-limiting’ genetic modification of mosquitoes – which, for example, renders them infertile or produce infertile offspring – gene drive works by unleashing a mutated gene that spreads rapidly through the species.
By developing a vaccine that targets specific cells in the immune system, researchers have seen a much greater immune and antibody response to the vaccine.
A type of mosquito that transmits malaria has been detected in Ethiopia for the first time, and the discovery has implications for putting more people at risk for malaria in new regions.
Uzbekistan becomes the second country in 2018 to be certified malaria-free – Paraguay was certified in June.
Researchers have, for the first time, detected the malaria parasite Plasmodium falciparum in India’s rhesus and bonnet monkeys and called for intensive surveillance to determine whether this has any implications for the country’s malaria-control program.
Reductions in malaria cases have stalled after several years of decline globally, according to the new World malaria report 2018. To get the reduction in malaria deaths and disease back on track, the World Health Organization (WHO) and partners are joining a new country-led response to scale up prevention and treatment, and increase investment, to protect vulnerable people from the deadly disease.
This increase occurred amidst a massive decline in the number of people protected by indoor residual spraying: 2.7 million people in 2015 compared to roughly 30,000 in 2016.